CN1020850C - 疤痕净美容霜及其制法 - Google Patents
疤痕净美容霜及其制法 Download PDFInfo
- Publication number
- CN1020850C CN1020850C CN 91105837 CN91105837A CN1020850C CN 1020850 C CN1020850 C CN 1020850C CN 91105837 CN91105837 CN 91105837 CN 91105837 A CN91105837 A CN 91105837A CN 1020850 C CN1020850 C CN 1020850C
- Authority
- CN
- China
- Prior art keywords
- herba alii
- alii fistulosi
- parts
- extract
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006071 cream Substances 0.000 title claims abstract description 10
- 230000003796 beauty Effects 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title abstract description 3
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 26
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 13
- 229960000458 allantoin Drugs 0.000 claims abstract description 13
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000008278 cosmetic cream Substances 0.000 claims description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 17
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 16
- 235000021355 Stearic acid Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 9
- 239000008117 stearic acid Substances 0.000 claims description 9
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 8
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 claims description 8
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 235000013599 spices Nutrition 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000035943 smell Effects 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 4
- 230000002159 abnormal effect Effects 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- 238000010025 steaming Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 150000002191 fatty alcohols Chemical class 0.000 abstract description 3
- 231100000241 scar Toxicity 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 208000003251 Pruritus Diseases 0.000 abstract description 2
- 230000007803 itching Effects 0.000 abstract description 2
- 230000029663 wound healing Effects 0.000 abstract description 2
- 208000032544 Cicatrix Diseases 0.000 abstract 1
- 229940072113 onion extract Drugs 0.000 abstract 1
- 230000037387 scars Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 6
- 210000000589 cicatrix Anatomy 0.000 description 5
- 244000291564 Allium cepa Species 0.000 description 4
- 235000010167 Allium cepa var aggregatum Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000234282 Allium Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101100494265 Caenorhabditis elegans best-15 gene Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101100004286 Caenorhabditis elegans best-5 gene Proteins 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003616 anti-epidemic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000286 mucous membrane, eye irritation or corrosion testing Toxicity 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
本发明涉及疤痕净美容霜及其制法,本发明提供一种以大葱提取物为主体,配入高级脂肪醇,促进伤口愈合的氮酮及尿囊素,以及表面活性剂等乳化而成。本发明产品能使疤痕组织软化和平复,消除疤痕的痒痛感,并无明显副作用。
Description
本发明涉及化妆品领域,特别是含有作为植物提取物的大葱提取物的皮肤用配制品。
葱汁是从大葱的叶或全株捣取得来的,它性味辛、温,散瘀、解毒。在《现代实用中药》中载有:“葱汁外用于化脓病疮面,促生肉芽”(《中药大辞典》,1986年5月1版,上海科学技术出版社,第2318页)。SU990230也从洋葱中提取具有抗微生物作用的苷的甾类化合物,洋葱与中国大葱都是葱属植物,其提取物有相近功能。
大葱(Allium fistutosum L.)提取物含有多种维生素如VC、VB、V
、痕量VA,还含有烟酸、棕榈酸、硬脂酸、20%纤维素、3%半纤维素、41%原果胶及24%水溶性果胶、葡萄糖、蔗糖、果糖、麦芽糖及低果聚糖。大葱不但能消毒,消肿,散瘀,并对多种杆菌、球菌和真菌有抑制作用。中国自古以来除用葱汁作内服药剂外,曾用葱汁治火焰丹毒、外痔、乳痈等。
国外都是从洋葱提取药物,如治疗气喘病药物(DE3305951 A1)、抗氧化剂(日本公开特许公报(A)、昭62-179587),洋葱提取物药物制剂(日本公开特许公报、昭53-9309)等,但未见有用中国大葱制备化妆品的报道。
本发明目的在于:提供一种主要含大葱提取物的疤痕净美容霜,该美容霜能缩小或消除受各种伤害如烫伤、烧伤、手术治疗所留下的疤痕,使皮肤平复,增强弹性。
本发明目的是这样达到的:以大葱提取物为主体,配入高级脂肪醇、促进伤口愈合的氮酮和尿囊素以及表面活性剂等乳化而成。
以下结合附图对本发明进行详细说明。
附图1是本发明美容霜的工艺流程方框图。
本发明美容霜是以大葱提取物为主体的化妆品,大葱提取物的制法如下:
将原料大葱洗净,用去离子水冲洗1~2次,晾干,过磅备用;以上述晾干的大葱与去离子水重量比为1∶0.6~1.0进行蒸煮,直至所收集的挥发油水无强烈挥发油气味为止,得到大葱挥发油水,待滞留在蒸煮罐内的液体达到原料大葱的重量1/4时,放出罐内液体,过滤入桶,得到水相大葱提取物,所收集的挥发油水以乙醚萃取,除去乙醚后即得到油相大葱提取物。在本
美容霜中所用大葱提取物由上述水相大葱提取物和油相大葱提取物组成,共用10~20份,最好15份,其中,水相提取物对油相提取物的重量比为50∶0.1。
本发明美容霜中还加入下列各成分:
尿囊素(Allantoin),为无色或白色结晶粉末,是由乙醛酸合成的日化产品添加剂,能溶于水及乙醇。尿囊素具有软化角质蛋白的作用,也有抗皱、护发作用。可充分赋予肌肤、毛发及口唇以柔软、光泽等效果,本美容霜中尿囊素用8~13.4份,最好10份。
氮酮(商品名)学名是月桂氮
酮,是无色到微黄色、无味的油状液体,属于高效皮肤渗透促进剂,它的优点是:既能极大地促进皮肤对药物及营养物质的吸收,又对皮肤机能无损伤,无刺激;与皮肤接触时润滑感强,涂展性能好,无气味,无毒;用量小,效果显著;因此宜于作皮肤渗透剂。在本美容霜中用0.5~1.2份,最好0.7份。
硬脂酸,不溶于水,用作珠光调理剂,使美容霜不但具有明亮珍珠光泽的外观,而且也有调理、增稠、柔软等作用,在本美容霜用4~6份,最好5份。
平平加(商品名Peregalo 15),学名为脂肪醇聚氧乙烯醚,为黄色膏状物,易溶于水,用后易洗去,有润湿能力,并能发泡。在本美容霜中用作扩散剂、渗透剂,用0.5~1.0份,最好0.7份。
十八醇是高级脂肪醇,与表面活性剂发生乳化作用,含有羟值185~230,本美容霜用1.8~3份,最好2.5份。
十二烷基硫酸钠是一种重要的阴离子表面活性剂,具有溶解性、泡沫性和去污性的最好平衡,在本美容霜中用0.2~0.6份,最好0.4份。
此外,还加入适量作为防腐剂例如尼泊金乙酯(对羟基苯甲酸乙酯)、适量香料和水。
从附图1可见,将作为水相原料的尿囊素8~13.4份,最好10份;十二烷基硫酸钠0.2~0.6份,最好0.4份;平平加0.5~1.0份,最好0.7份及适量水在95℃加热30分钟并搅拌;另外将作为油相原料的十八醇1.8~3份,最好是2.5份;氮酮0.3~1.2份,最好是0.7份;硬脂酸4~6份,最好是5份在95℃加热30分钟,并搅拌,放入上述水相原料中,得到混合的乳化均质物,使该均质物冷却,加入大葱提取物10~20份,最好15份和适量防腐剂,以及适量香料,即可贮藏、包装,得到
本发明疤痕净美容霜成品。
本美容霜经江苏省卫生防疫站检验,所用检验方法是GB7917-87、GB7918-87,其中铅、汞、砷、细菌含量都符合规定标准,不含粪大肠菌群、绿脓杆菌等。又经江苏省标准局日用化工产品质量监督检验站检测,其色泽、香气、膏体结构、耐热、耐寒、PH值均符合QB963-85标准。
此外,在江苏省实验动物中心进行了急性毒性试验(经口),其中,用昆明小鼠作实验动物,结果LD50大于10000mg/kg,按GB7919-87分级标准属无毒级。又在该中心进行了急性眼刺激试验,其中,以新西兰兔作实验动物,结果按GB7919-87分级标准积分为零,其眼刺激强度属“无刺激性”。
在1989年7月到1990年2月江苏省人民医院皮肤科、扬州市皮肤病防治所门诊部、扬州市苏北人民医院皮肤科、靖江县皮肤病防治门诊部四个单位对本发明疤痕净美容霜作过临床应用130例,从其中106个完整病历资料证明:该霜剂对减轻和消除疤痕的痒、痛自觉症状效果明显;对减退色素、促使疤痕组织软化和平复有一定效果。
本美容霜对妇女面部蝴蝶斑、青春痘疤痕、冻疮疤痕均有一定疗效。
本美容霜使用方便,无明显副作用。能够治疗或减轻由于意外刀伤、烫伤、手术等留下的各类疤痕疙瘩、肥大性受限疤痕等。
实施例:
大葱提取物的制法如下:
将原料大葱洗净,用去离子水冲洗2次,晾干,过磅,以该洗净大葱与去离子水比为1∶0.8进行蒸煮,直到所收集的挥发油水无强烈挥发油气味为止,得到大葱挥发油水,待滞留在蒸煮罐内的液体达到原料大葱的重量1/4时,放出罐内液体,过滤入桶,得到水相大葱提取物,所收集的挥发油水以乙醚萃取,除去乙醚后即得到油相大葱提取物。在本美容霜中所用大葱提取物由水相大葱提取物和油相大葱提取物组成,共用15份,其中水相提取物对油相提取物的重量比例为50∶0.1。
以尿囊素10份、十二烷基硫酸钠0.4份、平平加0.7份加适量水作为水相原料,在95℃加热30分钟并搅拌;以十八醇2.5份、氮酮0.7份、硬脂酸5份作为油相原料,在95℃加热30分钟,放入上述水相原料中,在得到乳化均质物后,冷却,然后加入15份大葱提取物及适量防腐剂和香料,即得到本发明疤痕净美容霜。
Claims (4)
1、一种美容霜,含有十二烷基硫酸钠、硬脂酸、防腐剂、香料、其特征在于:还含有包括水相提取物和油相提取物在内的大葱提取物、十八醇、平平加、氮酮、尿囊素,各成分含量(重量)如下:
1)大葱提取物 10~20份
将原料大葱洗净,用去离子水冲洗1~2次,晾干,过磅备用,以上述晾干的大葱与去离子水重量比为1∶0.6~1.0进行蒸煮,直至所收集的挥发油水无强烈挥发油气味为止,得到大葱挥发油水,待滞留在蒸煮罐内的液体达到原料大葱的重量1/4时,放出罐内液体,过滤入桶,得到水相大葱提取物,所收集的挥发油水以乙醚萃取,除去乙醚后即得到油相大葱提取物,在本美容霜中所用大葱提取物由上述水相大葱提取物和油相大葱提取物组成,共用10~20份,其中,水相提取物对油相提取物的重量比为 50∶0.1;
2)尿囊素 8~13.4份;
3)氮酮 0.5~1.2份
4)硬脂酸 4~6份
5)平平加 0.5~1.0份
6)十八醇 1.8~3份
7)十二烷基硫酸钠 0.2~0.6份
2、按照权利要求1所说的美容霜,其特征在于:所说的大葱提取物15份、尿囊素10份、氮酮0.7份、硬脂酸5份、平平加0.7份、十八醇2.5份、十二烷基硫酸钠0.4份。
3、一种美容霜的制法,其特征在于:将原料大葱洗净,用去离子水冲洗1~2次,晾干,以上述晾干的大葱与去离子水比为1∶0.6~1.0进行蒸煮,直到所收集的挥发油水无强烈挥发油气味为止,得到大葱挥发油水,待滞留在蒸煮罐内的液体达到原料大葱的重量1/4时,放出罐内液体过滤入桶,得到水相大葱提取物,所收集的挥发油水以乙醚萃取,除去乙醚后即得到油相大葱提取物,所用大葱提取物由上述水相大葱提取物和油相大葱提取物组成,共用10~20份,其中水相提取物对油相提取物的重量比为50∶0.1,将作为水相原料的适量水、尿囊素8~13.4份、十二烷基硫酸钠0.2~0.6份、平平加0.5~1.0份,在95℃加热30分钟并搅拌,再将作为油相原料的十八醇1.8~3份、氮酮0.5~1.2份、硬脂酸4~6份在95℃加热30分钟并搅拌,然后将加热的油相原料加到水相原料中去并混合,得到乳化均质物,使该乳化均质物冷却,加入大葱提取物10~20份,适量防腐剂例如尼泊金乙酯及香料,即可贮藏、包装,得到成品疤痕净美容霜。
4、按照权利要求3所说的美容霜制法,其特征在于:所说的各成分含量(重量)如下:
大葱提取物 15份
尿囊素 10份
氮酮 0.7份
平平加 0.7份
十八醇 2.5份
硬脂酸 5份
十二烷基硫酸钠 0.4份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 91105837 CN1020850C (zh) | 1991-08-28 | 1991-08-28 | 疤痕净美容霜及其制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 91105837 CN1020850C (zh) | 1991-08-28 | 1991-08-28 | 疤痕净美容霜及其制法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1058529A CN1058529A (zh) | 1992-02-12 |
CN1020850C true CN1020850C (zh) | 1993-05-26 |
Family
ID=4907354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 91105837 Expired - Fee Related CN1020850C (zh) | 1991-08-28 | 1991-08-28 | 疤痕净美容霜及其制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1020850C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1055214C (zh) * | 1995-01-16 | 2000-08-09 | 周福田 | 治疗后天性疤痕的中药药液的生产方法及产品 |
CN1091592C (zh) * | 1999-02-03 | 2002-10-02 | 王有仁 | 一种治疗烧伤的生物乳及其制备方法 |
CN101204501B (zh) * | 2006-12-21 | 2011-04-27 | 张介眉 | 防治脂肪肝的中药及葱白提取物在防治脂肪肝的应用 |
CN103720626B (zh) * | 2014-01-28 | 2015-09-02 | 陈爱丽 | 果蔬面膜及其制备方法 |
CN106137863B (zh) * | 2016-08-19 | 2019-01-18 | 澳思美日用化工(广州)有限公司 | 一种婴幼儿用多效润肤膏 |
CN107028830B (zh) * | 2017-04-25 | 2021-03-09 | 徐子雁 | 一种防止疤痕增生的药品及其制备工艺 |
-
1991
- 1991-08-28 CN CN 91105837 patent/CN1020850C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1058529A (zh) | 1992-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108096117B (zh) | 一种组合物及其制备方法和应用 | |
CN105106655A (zh) | 一种修复性烧伤烫伤膏及其制备方法 | |
JP4495406B2 (ja) | センダングサ属植物抽出物含有組成物 | |
CN107157910A (zh) | 一种具有双重保湿功效的护肤组合物及其制备方法与应用 | |
US5676957A (en) | Skin external agent | |
CN109010178B (zh) | 一种沐浴露及其生产工艺 | |
CN108451806B (zh) | 一种天然抗敏保湿组合物及其制备方法和应用 | |
CN1020850C (zh) | 疤痕净美容霜及其制法 | |
Davkhar et al. | Formulation and Evaluation of Multipurpose Herbal Cream. | |
KR101732906B1 (ko) | 병풀추출물, 목련수피 추출물, 나한백가지 추출물, 유칼립투스잎오일, 보리지씨오일을 유효성분으로 하는 피부진정 및 아토피 개선용 화장료 조성물 | |
KR20140145278A (ko) | 피부 수렴 및 탄력 효과를 갖는 승마 추출물, 산수유 추출물 및 현초 추출물을 함유하는 화장료 조성물. | |
CN113679640A (zh) | 一种天然滋养净肤护肤祛痘洁面凝露及其制备方法 | |
CN105853293A (zh) | 具有美白作用的化妆品组合物及护手霜 | |
KR101926080B1 (ko) | 비누 조성물 및 이를 포함하는 비누 | |
JP4871438B2 (ja) | 化粧料 | |
CN110613663A (zh) | 一种皮肤修护组合物、护肤品及其制备方法 | |
CN106166123A (zh) | 具有抗敏止痒功效的护肤组合物、乳液及其制备方法 | |
CN111067849B (zh) | 一种适用于婴儿皮肤的洗手液的制备方法 | |
CN104224604A (zh) | 一种植物美白去斑修复霜 | |
CN107320417A (zh) | 一种百年草祛疤组合物的制备方法 | |
CN113476387A (zh) | 一种含有中药有效成分的滋养乌发防脱发止痒的洗发水及其制备方法 | |
CN105997645A (zh) | 一种多重保湿卸妆乳及其制备方法 | |
KR100331675B1 (ko) | 피부외용제 | |
CN104288059A (zh) | 一种化妆品组合物 | |
KR20080097314A (ko) | 참나무 속 식물추출물을 함유하는 모공수축용 화장료조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |